Literature DB >> 33331986

The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases.

Fei Song1, Xiao-Xia Zhou1, Yu Hu1, Gang Li2, Yan Wang3.   

Abstract

The insulin-like growth factor (IGF) system comprises ligands of IGF-I/II, IGF receptors (IGFR), IGF binding proteins (IGFBPs), and IGFBP hydrolases. The IGF system plays multiple roles during various disease development as IGFs are widely involved in cell proliferation and differentiation through regulating DNA transcription. Meanwhile, IGFBPs, which are mainly synthesized in the liver, can bind to IGFs and perform two different functions: either inhibition of IGFs by forming inactive compounds with IGF or enhancement of the function of IGFs by strengthening the IGF-IGFR interaction. Interestingly, IGFBPs may have wider functions through IGF-independent mechanisms. Studies have shown that IGFBPs play important roles in cardiovascular disease, tumor progression, fetal growth, and neuro-nutrition. In this review, we emphasize that different IGFBP family members have common or unique functions in numerous diseases; moreover, IGFBPs may serve as biomarkers for disease diagnosis and prediction.

Entities:  

Keywords:  Disease development; Insulin-like growth factor binding proteins; Insulin-like growth factors

Mesh:

Substances:

Year:  2020        PMID: 33331986     DOI: 10.1007/s12325-020-01581-x

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  79 in total

1.  Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.

Authors:  Klas Ekström; Jenny Salemyr; Ingmar Zachrisson; Christine Carlsson-Skwirut; Eva Ortqvist; Peter Bang
Journal:  Diabetes Care       Date:  2007-03-19       Impact factor: 19.112

Review 2.  The IGF-1 receptor in cancer biology.

Authors:  Renato Baserga; Francesca Peruzzi; Krysztof Reiss
Journal:  Int J Cancer       Date:  2003-12-20       Impact factor: 7.396

Review 3.  Insulin-like growth factors and neoplasia.

Authors:  Michael N Pollak; Eva S Schernhammer; Susan E Hankinson
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

4.  Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3.

Authors:  J L Chicharro; A López-Calderon; J Hoyos; A I Martín-Velasco; G Villa; M A Villanúa; A Lucía
Journal:  Br J Sports Med       Date:  2001-10       Impact factor: 13.800

Review 5.  Insulin-like growth factor binding protein-1: recent findings and new directions.

Authors:  P D Lee; L C Giudice; C A Conover; D R Powell
Journal:  Proc Soc Exp Biol Med       Date:  1997-12

6.  Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes.

Authors:  Daniela Kiepe; Tim Ulinski; David R Powell; Susan K Durham; Otto Mehls; Burkhard Tönshoff
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

Review 7.  Role of insulin-like growth factor binding proteins in the control of IGF actions.

Authors:  D R Clemmons; W H Busby; T Arai; T J Nam; J B Clarke; J I Jones; D K Ankrapp
Journal:  Prog Growth Factor Res       Date:  1995

8.  IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes.

Authors:  Märit Wallander; Anna Norhammar; Klas Malmberg; John Ohrvik; Lars Rydén; Kerstin Brismar
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

9.  Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers.

Authors:  Vanessa I Ramirez; Evelyn Miller; Christiane L Meireles; Jonathan Gelfond; Debra A Krummel; Theresa L Powell
Journal:  BMJ Open Diabetes Res Care       Date:  2014-04-23
View more
  1 in total

Review 1.  Hepatocrinology.

Authors:  Sanjay Kalra; Saptarshi Bhattacharya; Pawan Rawal
Journal:  Med Sci (Basel)       Date:  2021-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.